avapro and Uremia
avapro has been researched along with Uremia in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "In captopril-treated HS-2 rats, glomerular filtration rate decline and mortality were significantly blunted as compared with all other groups (50% mortality after week 12)." | 1.33 | Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats. ( Aladjem, M; Averbukh, Z; Berman, S; Cohn, M; Efrati, S; Galperin, E; Modai, D; Rapoport, M; Weissgarten, J, 2005) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Weissgarten, J | 1 |
| Berman, S | 1 |
| Efrati, S | 1 |
| Rapoport, M | 1 |
| Modai, D | 1 |
| Cohn, M | 1 |
| Aladjem, M | 1 |
| Galperin, E | 1 |
| Averbukh, Z | 1 |
Other Studies
1 other study available for avapro and Uremia
| Article | Year |
|---|---|
Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihype | 2005 |